Paul has built an extensive experiences in the Asset Finance Industry and deep Knowledge in Accounting and Global Transitions. An experienced change management and asset finance Leader specialised in delivering business integration and process improvement across Europe.
Formerly Finance Director in France for a major international leasing company, Paul has an impressive track record in delivering complex programs of projects against aggressive timescales, from acquisition integrations through program delivery to business transformations and IT system implementations.
A Chartered Accountant and fluent French, German & Spanish speaker Paul was Finance Director of a major US investment Bank in France and Germany prior to moving into leasing. As a certified Six Sigma Master Black Belt and an acknowledged specialist in process improvement, Paul has delivered bottom line benefits to many European leasing & fleet operations.
John Jimenez is a Clinical Data Manager and Data Steward with over seven years of experience in clinical research and digital health innovation. He specializes in data governance, interoperability, and regulatory compliance across global studies, driving initiatives that enhance data accessibility and quality in the pharmaceutical and nutrition sectors. John is passionate about leveraging technology and cross-functional collaboration to build more transparent and efficient research ecosystems.
AI & Digital Innovation Leader | Biopharma Executive | Startup Advisor & Investor
→ I help biopharma companies navigate and lead the future of healthcare through AI, digital strategy, and innovation.
→ With nearly 20 years of experience across commercial, clinical, and enterprise functions, I’ve held senior leadership roles at top pharma companies, including BMS, Novartis, and Biogen.
→ Most recently, I served as VP and Head of Global Digital Strategy at Bristol Myers Squibb, where I was accountable to the Executive Leadership Team and Board of Directors for driving enterprise-wide digital innovation. Prior to that, I was a founding member of the Novartis BIOME, a global network of digital innovation hubs.
Nacho has built his career in the automotive and mobility industry, holding key roles in sales, fleet, and business development at companies such as Ford Motor Company and PepsiCo. As Founder and COO of Flexivan, part of the Flexicar Group, he focuses on delivering flexible vehicle renting and mobility solutions for companies and private clients. With a strong background in commercial strategy and operations, he brings a pragmatic approach to innovation and sustainable mobility.
Clinical Research Leader with extensive experience overseeing pharmaceutical trials within oncological, central nervous system, rare disease, and infectious disease therapies, leveraging an intuitive blend of interpersonal skills to maintain cross-functional collaboration across internal and external stakeholders.
Knowledgeable and respectful team player adept at building trust and mutual respect among vendors
and team members to ensure quality execution. Highly motivated clinical operations specialist
employing dedication, work ethic, flexibility, and an unwavering drive to improve patient lives through
research trials.
Marilyn Kludt, Senior Project Director, Oncology, at Premier Research is highly experienced in clinical development within the CRO, pharmaceutical, and biotech environments. Her emphasis is in Global Project Management, Strategic Alliances, Functional Service Provisioning, and Global Clinical Operations. Marilyn has experience in Phases I-IV across extensive therapeutic areas with the most recent 12 years focused on early phase international programs in oncology and haematology. Her unique experience includes FIH, Head and Neck TIL infusion, CAR T-cell therapy, and Richter’s Transformation.
Experienced more than 20+ years in clinical operations and clinical development. Demonstrated history in variety of companies including large pharma, start-up and CRO industries. Experienced in a variety of therapy areas including oncology (solid and hematological), neurology, HIV and respiratory. Line and matrix team management in programs from first time in human (FTIH) to phase III in a variety of populations (patient, pediatric, healthy volunteer) and study designs. Experienced in providing leadership and support within multiple collaborative teams to effectively led programs to successful submissions in multiple new investigational drugs and medical device.
